Guard Therapeutics International AB (publ) (STO: GUARD)

Market Cap	352.03M
Revenue (ttm)	n/a
Net Income (ttm)	-78.82M
Shares Out	12.06M
EPS (ttm)	-7.80
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	483
Open	29.20
Previous Close	28.20
Day's Range	28.60 - 29.20
52-Week Range	6.78 - 49.80
Beta	-0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 2, 2024

About GUARD

Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is ba...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 11
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: GUARD